7:20 am – 7:30 am 7:30 am – 7:50 am 7:50 am – 8:05 am 8:05 am – 8:20 am 8:20 am – 8:35 am 8:35 am – 8:50 am 8:50 am – 9:00 am 9:00 am – 9:15 am 9:15 am – 9:45 am 9:45 am – 10:00 am 10:00 am – 10:10 am 10:10 am – 10:25 am 10:10 am 10:17 am 10:25 am – 10:45 am 10:45 am – 11:00 am 11:00 am – 11:30 am 11:30 am – 11:45 am 12:45 pm – 12:55 pm 12:55 pm – 1:05 pm 1:05 pm – 1:15 pm 1:15 pm – 2:15 pm -Active Surveillance – Stacy Loeb, MD -Androgen Deprivation Therapy – Amir Lebatschi, MD -Cryo – Thomas Polascik, MD, FACS -HIFU – Caroline Moore, MD -Radiation – Amar Kishan, MD -Salvage Radical Prostatectomy – Peter Pinto, MD 3:00 pm – 3:30 pm 3:30 pm – 4:30 pm 3:00 pm – 3:10 pm 3:10 pm – 3:20 pm 3:20 pm – 3:30 pm 3:30 pm – 3:40 pm 3:40 pm – 3:50 pm 3:50 pm – 4:00 pm 4:00 pm – 4:10 pm 4:10 pm – 4:20 pm 4:20 pm – 4:30 pm 4:30 pm – 6:00 pm 4:30 pm – 6:00 pm 7:00 am – 7:30 am 7:30 am – 8:30 am 7:00 am – 7:10 am 7:10 am – 7:20 am 7:20 am – 7:30 am 7:30 am – 7:40 am 7:40 am – 7:50 am 7:50 am – 8:00 am 8:00 am – 8:10 am 8:10 am – 8:20 am 8:20 am – 8:30 am 8:30 am – 10:00 am 8:30 am – 10:00 am 10:30 am – 10:40 am 10:40 am – 10:50 am 10:50 am – 11:00 am 11:00 am – 11:15 am 11:15 am – 11:30 am 11:30 am – 11:50 am 11:50 am – 12:00 pm 12:00 pm – 1:00 pm 1:00 pm – 1:15 pm 1:15 pm – 2:00 pm 2:00 pm – 2:15 pm 2:15 pm – 2:25 pm 2:25 pm – 2:40 pm 2:40 pm – 2:55 pm 2:55 pm – 3:05 pm 3:05 pm – 3:20 pm 3:20 pm – 3:30 pm 3:30 pm – 3:40 pm 3:40 pm – 3:50 pm 3:50 pm – 4:00 pm 4:00 pm – 4:05 pmSchedule
Friday, October 22, 2021
SESSION 1: PROSTATE IMAGING
Welcome - Arvin K. George, MD
Prostate MRI for the Urologist
Baris Turkbey, MD
The Manogram: Role of MRI in Prostate Cancer Screening
Peter A. Pinto, MD
DiscussionSESSION 2: INTRODUCTION TO FOCAL THERAPY
Rationale for Focal Therapy
Jim Wysock, MD
Patient Selection - Uses and Misuses of Focal Therapy
Laurence Klotz, MD
PET Imaging for Selection of Focal Therapy Candidates
TBD, MD
Discussion
BREAK
Focal Therapy vs. Active Surveillance for Low Volume GG2 Disease
Stacy Loeb, MD
Prostate Cancer Biomarkers and Focal Therapy
Simpa S. Salami, MD
Point Counterpoint:
Focal Therapy Can Be Done for MRI Invisible Disease: Arvin George, MD
Focal Therapy Should Not Be Done for MRI Invisible Disease: Simpa S.Salami, MD
Introduction of Disruptive Technologies: The Lessons from the Minimally Invasive Surgery
Inderbir S. Gill, MD
Discussion
KEYNOTE LECTURE: The Unlikely Candidates: Focal Therapy for Low and High-Risk Prostate Cancer Patients
Caroline Moore, MD
DiscussionSESSION 3: PRINCIPLES OF FOCAL TREATMENT
Modalities, Maps and Margins: Optimizing Oncologic Efficacy
Rafael Sanchez Salas, MD
Patient Safety: Operative Techniques to Minimize Morbidity
Lance Mynderse, MD
Discussion
Balloon Debate: Optimal Management of Radio-Recurrent Unifocal Disease
Moderator: Abhinav Sidana, MD, MPHCONCURRENT HANDS-ON COURSE II: IN-OFFICE TRANSPERINEAL INTERVENTIONS
In-Office Transperineal Interventions
Arvin K. George, MD
Live Hands-on Lab*CONCURRENT HANDS-ON COURSE I: STATE-OF-THE-ART BPH MANAGEMENT
Introduction – Workup/Guidelines
Amin S. Herati, MD
Rezum – Christopher Dixon, MD
Urolift - Amin S. Herati, MD
Enucleation – John Wei, MD
iTind - Jonathan N. Warner, MD
Aquablation – Brian Helfand, MD, PhD
Summary - Amin S. Herati, MD
Discussion
BREAK
Live Hands-on Lab*CONCURRENT HANDS-ON COURSE III: FUSION GUIDED ABLATION
Live Hands-on Lab*
Saturday, October 23, 2021
CONCURRENT HANDS-ON COURSE II: IN-OFFICE TRANSPERINEAL INTERVENTIONS
In-Office Transperineal Interventions
Arvin K. George, MD
Live Hands-on Lab*CONCURRENT HANDS-ON COURSE I: STATE-OF-THE-ART BPH MANAGEMENT
Introduction – Workup/GuidelinesI
Amin S. Herati, MD
Rezum – Christopher Dixon, MD
Urolift - Amin S. Herati, MD
Enucleation – John Wei, MD
iTind - Jonathan N. Warner, MD
Aquablation – Brian Helfand, MD, PhD
Summary - Amin S. Herati, MD
Discussion
BREAK
Live Hands-on Lab*CONCURRENT HANDS-ON COURSE III: FUSION GUIDED ABLATION
Live Hands-on Lab*SESSION 4: SURVEILLANCE AND OUTCOME ASSESSMENT AFTER FOCAL THEAPY
Role of PSA and Biomarkers in Assessing Focal Therapy Success
TBD
MRI Imaging After Focal Therapy: What and When?
Baris Turkbey, MD
Protocol Biopsy for Surveillance After Focal Therapy
Kia Michel, MD
DiscussionSESSION 5: FOCAL THERAPY CHALLENGES AND CASE DISCUSSIONS
Complications of Focal Therapy - Risk Factors, Timepoints, Management
Rafael Sanchez Salas, MD
Mechanisms and Management of Recurrence
TBD
Discussion
LUNCH (Industry Sponsored)
Abstract Presentations
Andre Abreu, MD
Case Discussions
Andre Abreu, MD, Jonathan Coleman, MD, Rafael Sanchez Salas, MD
Outcomes of Existing Focal Therapy Energy Modalities
Amir Lebastchi, MD
Focal Therapy Society Update
Thomas Polascik, MD, FACS
DiscussionSESSION 6: STARTING A FOCAL THERAPY PROGRAM
Block by Block: Building a Focal Therapy Program
Art Rastinehad, DO
Billing and Reimbursement*
Karen Cornett, Hugo Embert
DiscussionSESSION 7: FUTURE OF FOCAL THERAPY
Prostate Ablation and Antitumor Immune Response
Abhinav Sidana, MD, MPH
Triopsy: Precision Sampling and Localization of Prostate Cancer
E. David Crawford, MD
New Modality #1*
New Modality #2*
Conclusion